Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose Response, Randomized, Controlled, Double-blind, Cross-over Trial to Determine the LDL Cholesterol Lowering Effect of Ground Flaxseed in Adults With Above Optimal Plasma LDL Concentrations

NCT01821131 is registered in ClinicalTrials.gov with St. Boniface Hospital as lead sponsor.

NCT NCT01821131
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01821131 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose Response, Randomized, Controlled, Double-blind, Cross-over Trial to Determine the LDL Cholesterol Lowering Effect of Ground Flaxseed in Adults With Above Optimal Plasma LDL Concentrations
Lead sponsor
St. Boniface Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2014
Completion date
January 31, 2025
Enrollment
76 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

above optimal plasma ldl concentrations